Financials
- Market Capitalization 2.09 B
- Employee 647
- Founded 2004
- CEO N/A
- Website www.admabiologics.com
- Headquarter Delaware, United States
- FIGI BBG002NCK5M5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
11.96
市销率
3.92
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +15.67% | +129.58% | 2.13 B USD | ||
| 1972 | VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -4.05% | -10.94% | +12.65% | 2.10 B USD | ||
| 1994 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +10.48% | +59.78% | 2.04 B USD | ||
| 1996 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.27 USD | -4.14% | -3.49% | -2.52% | +18.18% | 2.04 B USD |